Skip to main content

Find Clinical Trials

Home
Conditions
CD20-positive Hematological Malignancies

Clinical trial condition

CD20-positive Hematological Malignancies

Explore clinical trials studying CD20-positive Hematological Malignancies. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

CD20-positive Hematological Malignancies trial results

Not Yet Recruiting

Phase I Clinical Trial of TQB2825 Subcutaneous Injection in CD20-positive Hematological Malignancies

NCT07110194

Conditions: CD20-positive Hematological Malignancies
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details